An in-depth look to NANG KUANG PHARMACEUTICAL CO operating, investing, and financing activities

1752 free cash flow for Q3 24 is 106.82 M TWD. For 2023, 1752 free cash flow was 45.06 M TWD and operating cash flow was 341.71 M TWD.